1,390
Total Claims
$893K
Drug Cost
218
Beneficiaries
$4,097
Cost/Patient
Peer Comparison vs. 9,082 Pulmonary Disease providers
-20%
Cost per patient vs peers
$4,097 vs $5,138 avg
+63%
Brand preference vs peers
100.0% vs 61.4% avg
Brand vs Generic
0% generic
Brand: 918 claims · $875K
Generic: 0 claims · $0
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Nintedanib Esylate | 20 | $271K |
| Fluticasone/Umeclidin/Vilanter | 320 | $269K |
| Fluticasone/Vilanterol | 90 | $46K |
| Tiotropium Bromide | 56 | $41K |
| Budesonide/Formoterol Fumarate | 72 | $39K |
| Umeclidinium Brm/Vilanterol Tr | 66 | $37K |
| Tiotropium Br/Olodaterol Hcl | 40 | $22K |
| Budesonide/Glycopyr/Formoterol | 18 | $16K |
| Fluticasone Propion/Salmeterol | 31 | $13K |
| Fluticasone Propion/Salmeterol | 24 | $6,325 |
| Albuterol Sulfate | 128 | $4,103 |
| Fluticasone Propion/Salmeterol | 13 | $3,668 |
| Fluticasone Furoate | 13 | $3,216 |
| Montelukast Sodium | 171 | $2,554 |
| Albuterol Sulfate | 26 | $1,705 |
Prescribing Profile
16
Unique Drugs
Patient Profile
74
Avg Age
60%
Female
2.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About